Join this webinar to find out the latest on the Ebola Bundibugyo virus outbreak: current trends, response efforts, opera...
Join this webinar to find out the latest on the Ebola Bundibugyo virus outbreak: current trends, response efforts, operational priorities, clinical trials of therapeutics and vaccine candidates, and readiness measures.
Since May 2026, the outbreak of Ebola disease caused by Bundibugyo virus (BVD) has become the largest Ebola outbreak recorded in the Democratic Republic of the Congo, surpassing 10,000 confirmed cases. The outbreak has also spread beyond the DRC, with cases reported in Uganda, France, Kenya and Nigeria, underscoring the growing risk of cross-border transmission and the need for coordinated preparedness. While the outbreak remains a major public health challenge, important advances are being made, including the launch of clinical trials for therapeutics and vaccine candidates. This EPI-WIN webinar will provide the latest situation update, share response achievements and challenges and operational priorities, and highlight actions to strengthen readiness at global, regional and country levels.
Objectives
Provide an overview of the current global and regional BVD epidemiological situation.
Highlight preparedness and readiness activities being undertaken by WHO, partners and countries.
Identify key challenges, lessons learned and priorities for strengthening response efforts.
Present updates on progress in clinical trials of therapeutics and vaccine candidates
Agenda and Speakers
Introduction of EPI-WIN, housekeeping and slido: Dr Supriya Bezbaruah, Lead, EPI-WIN Science and Knowledge Translation, WHO headquarters
Welcome remarks: Dr Chikwe Ihekweazu, WHO Health Emergencies Programme (WHE)
Global overview of the current BVD situation and epidemiological trends: Dr Zyleen Kassamali, Epidemiologist (Acute events), WHO Health Emergencies Programme
Health operations update: response achievements, emerging challenges, operational priorities, and preparedness actions: DrPatrick Otim Ramadan, Programme Area Manager (emergency response), Outbreak and Humanitarian Response, WHO Regional Office for Africa
Progress in clinical trials of therapeutics and candidate vaccines: Dr Meg Doherty, Director Science for Health, WHO headquarters (TBC) and country speaker (TBC)
Q&A
Closing and next webinar: EPI-WIN Science and Knowledge Translation, WHO headquarters
